Market Tracker

05/24 5:41am ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

13.31
Delayed Data
As of May 23
 -0.14 / -1.04%
Today’s Change
8.31
Today|||52-Week Range
32.74
-8.33%
Year-to-Date

Today’s Trading

Previous close13.45
Today’s open13.46
Day’s range13.20 - 13.72
Volume12,692,087
Average volume (3 months)21,243,136
Market cap$4.6B
Dividend yield--
Data as of 05/23/2017

Growth & Valuation

Earnings growth (last year)-716.47%
Earnings growth (this year)-32.57%
Earnings growth (next 5 years)-1.55%
Revenue growth (last year)-7.39%
P/E ratioNM
Price/Sales0.52
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...-4.42-3.94%
CTLTCatalent Inc+0.51+1.49%
PTHNPatheon NV-0.05-0.14%
AKRXAkorn Inc-0.02-0.06%
Data as of 05/23/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.96
Annual revenue (last year)$9.7B
Annual profit (last year)-$2.4B
Net profit margin-24.90%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Joseph C. Papa
Chief Financial Officer &
Executive VP-Finance
Paul S. Herendeen
Corporate headquarters
Laval, Quă©bec

Forecasts